位置:首页 > 蛋白库 > TCS1_CAMSI
TCS1_CAMSI
ID   TCS1_CAMSI              Reviewed;         369 AA.
AC   Q9FZN8; A5HF92; K9MNV5;
DT   03-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 53.
DE   RecName: Full=3,7-dimethylxanthine N-methyltransferase TCS1 {ECO:0000305};
DE            Short=TCS1a {ECO:0000303|PubMed:26773541, ECO:0000303|PubMed:30303011};
DE            EC=2.1.1.160 {ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668, ECO:0000269|PubMed:26773541, ECO:0000269|PubMed:30303011};
DE   AltName: Full=Caffeine synthase 1 {ECO:0000303|PubMed:10984041};
GN   Name=TCS1 {ECO:0000303|PubMed:10984041};
GN   Synonyms=TCS1A {ECO:0000303|PubMed:26773541, ECO:0000303|PubMed:30303011};
OS   Camellia sinensis (Tea).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; Ericales; Theaceae; Camellia.
OX   NCBI_TaxID=4442;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=10984041; DOI=10.1038/35023072;
RA   Kato M., Mizuno K., Crozier A., Fujimura T., Ashihara H.;
RT   "Caffeine synthase gene from tea leaves.";
RL   Nature 406:956-957(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Leaf;
RA   Deng W.W., Jiang C.J., Wang Z.X., Lee Y.Y., Shi R.J., Zhu L., Ye A.H.,
RA   Yu M.;
RT   "Cloning and analysis of Camellia sinensis TCS genomic DNA sequence for
RT   caffeine synthase.";
RL   Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Jin J.Q., Chen L., Ma C.L., Yao M.Z.;
RT   "Cloning and analysis of Camellia sinensis TCS genomic DNA sequence for
RT   caffeine synthase.";
RL   Submitted (AUG-2012) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 14-33, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10364410; DOI=10.1104/pp.120.2.579;
RA   Kato M., Mizuno K., Fujimura T., Iwama M., Irie M., Crozier A.,
RA   Ashihara H.;
RT   "Purification and characterization of caffeine synthase from tea leaves.";
RL   Plant Physiol. 120:579-586(1999).
RN   [5]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12527364; DOI=10.1016/s0014-5793(02)03781-x;
RA   Mizuno K., Okuda A., Kato M., Yoneyama N., Tanaka H., Ashihara H.,
RA   Fujimura T.;
RT   "Isolation of a new dual-functional caffeine synthase gene encoding an
RT   enzyme for the conversion of 7-methylxanthine to caffeine from coffee
RT   (Coffea arabica L.).";
RL   FEBS Lett. 534:75-81(2003).
RN   [6]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12860386; DOI=10.1016/s0014-5793(03)00670-7;
RA   Mizuno K., Kato M., Irino F., Yoneyama N., Fujimura T., Ashihara H.;
RT   "The first committed step reaction of caffeine biosynthesis: 7-
RT   methylxanthosine synthase is closely homologous to caffeine synthases in
RT   coffee (Coffea arabica L.).";
RL   FEBS Lett. 547:56-60(2003).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=16333668; DOI=10.1007/s00438-005-0070-z;
RA   Yoneyama N., Morimoto H., Ye C.-X., Ashihara H., Mizuno K., Kato M.;
RT   "Substrate specificity of N-methyltransferase involved in purine alkaloids
RT   synthesis is dependent upon one amino acid residue of the enzyme.";
RL   Mol. Genet. Genomics 275:125-135(2006).
RN   [8]
RP   REVIEW ON CAFFEINE BIOSYNTHESIS.
RX   PubMed=18068204; DOI=10.1016/j.phytochem.2007.10.029;
RA   Ashihara H., Sano H., Crozier A.;
RT   "Caffeine and related purine alkaloids: biosynthesis, catabolism, function
RT   and genetic engineering.";
RL   Phytochemistry 69:841-856(2008).
RN   [9]
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND INDUCTION BY DROUGHT.
RX   PubMed=20469645; DOI=10.1515/znc-2010-3-413;
RA   Kato M., Kitao N., Ishida M., Morimoto H., Irino F., Mizuno K.;
RT   "Expression for caffeine biosynthesis and related enzymes in Camellia
RT   sinensis.";
RL   Z. Naturforsch. C Biosci. 65:245-256(2010).
RN   [10]
RP   FUNCTION, MUTAGENESIS OF ARG-225; PHE-271; ALA-272 AND VAL-317, AND
RP   BIOTECHNOLOGY.
RX   PubMed=25133732; DOI=10.1371/journal.pone.0105368;
RA   Jin L., Bhuiya M.W., Li M., Liu X., Han J., Deng W., Wang M., Yu O.,
RA   Zhang Z.;
RT   "Metabolic engineering of Saccharomyces cerevisiae for caffeine and
RT   theobromine production.";
RL   PLoS ONE 9:e105368-e105368(2014).
RN   [11]
RP   FUNCTION, MUTAGENESIS OF SER-269, CATALYTIC ACTIVITY, GENE FAMILY, AND
RP   NOMENCLATURE.
RX   PubMed=26773541; DOI=10.1016/j.plaphy.2015.12.020;
RA   Jin J.-Q., Yao M.-Z., Ma C.-L., Ma J.-Q., Chen L.;
RT   "Natural allelic variations of TCS1 play a crucial role in caffeine
RT   biosynthesis of tea plant and its related species.";
RL   Plant Physiol. Biochem. 100:18-26(2016).
RN   [12]
RP   MUTAGENESIS OF HIS-153 AND PRO-332.
RX   PubMed=27116373; DOI=10.1016/j.plaphy.2016.04.032;
RA   Jin J.-Q., Yao M.-Z., Ma C.-L., Ma J.-Q., Chen L.;
RT   "Association mapping of caffeine content with TCS1 in tea plant and its
RT   related species.";
RL   Plant Physiol. Biochem. 105:251-259(2016).
RN   [13]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=30303011; DOI=10.1021/acs.jafc.8b03433;
RA   Jin J.Q., Chai Y.F., Liu Y.F., Zhang J., Yao M.Z., Chen L.;
RT   "Hongyacha, a naturally caffeine-free tea plant from Fujian, China.";
RL   J. Agric. Food Chem. 66:11311-11319(2018).
CC   -!- FUNCTION: Involved in the biosynthesis of caffeine (PubMed:10984041,
CC       PubMed:16333668, PubMed:26773541, PubMed:30303011, PubMed:25133732).
CC       Catalyzes the conversion of 7-methylxanthine (7mX) to theobromine and
CC       of theobromine to caffeine (PubMed:10984041, PubMed:16333668,
CC       PubMed:26773541, PubMed:30303011, PubMed:25133732). Has 3-N- and 1-N-
CC       methylation activity (PubMed:10984041, PubMed:16333668).
CC       {ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668,
CC       ECO:0000269|PubMed:25133732, ECO:0000269|PubMed:26773541,
CC       ECO:0000269|PubMed:30303011}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7-methylxanthine + S-adenosyl-L-methionine = H(+) + S-
CC         adenosyl-L-homocysteine + theobromine; Xref=Rhea:RHEA:24604,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28946, ChEBI:CHEBI:48991,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789; EC=2.1.1.160;
CC         Evidence={ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668,
CC         ECO:0000269|PubMed:26773541, ECO:0000269|PubMed:30303011};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24605;
CC         Evidence={ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668,
CC         ECO:0000269|PubMed:26773541};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-adenosyl-L-methionine + theobromine = caffeine + H(+) + S-
CC         adenosyl-L-homocysteine; Xref=Rhea:RHEA:20944, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:27732, ChEBI:CHEBI:28946, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789; EC=2.1.1.160;
CC         Evidence={ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668,
CC         ECO:0000269|PubMed:26773541, ECO:0000269|PubMed:30303011};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20945;
CC         Evidence={ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668,
CC         ECO:0000269|PubMed:26773541};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,7-dimethylxanthine + S-adenosyl-L-methionine = caffeine +
CC         H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:10280,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25858, ChEBI:CHEBI:27732,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789; EC=2.1.1.160;
CC         Evidence={ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10281;
CC         Evidence={ECO:0000269|PubMed:10984041, ECO:0000269|PubMed:16333668};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9FLN8};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:Q9FLN8};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=24 uM for paraxanthine {ECO:0000269|PubMed:10364410,
CC         ECO:0000269|PubMed:12527364, ECO:0000269|PubMed:12860386};
CC         KM=186 uM for 7-methylxanthine {ECO:0000269|PubMed:10364410,
CC         ECO:0000269|PubMed:12527364, ECO:0000269|PubMed:12860386};
CC         KM=344 uM for theobromine {ECO:0000269|PubMed:10364410,
CC         ECO:0000269|PubMed:12527364, ECO:0000269|PubMed:12860386};
CC         KM=21 uM for S-adenosyl-L-methionine {ECO:0000269|PubMed:10364410,
CC         ECO:0000269|PubMed:12527364, ECO:0000269|PubMed:12860386};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:10364410,
CC         ECO:0000269|PubMed:12527364, ECO:0000269|PubMed:12860386};
CC   -!- PATHWAY: Alkaloid biosynthesis. {ECO:0000269|PubMed:10984041}.
CC   -!- TISSUE SPECIFICITY: Expressed in young leaves and flowers.
CC       {ECO:0000269|PubMed:20469645}.
CC   -!- DEVELOPMENTAL STAGE: Expression declines during leaf development but
CC       remains constant throughout the flower development.
CC       {ECO:0000269|PubMed:20469645}.
CC   -!- INDUCTION: Down-regulated by drought. {ECO:0000269|PubMed:20469645}.
CC   -!- BIOTECHNOLOGY: Saccharomyces cerevisiae (Yeast) expressing Coffea
CC       arabica (coffee) xanthosine methyltransferase (CaXMT1) and Camellia
CC       sinensis (tea) caffeine synthase (TCS1) accumulates caffeine.
CC       {ECO:0000269|PubMed:25133732}.
CC   -!- SIMILARITY: Belongs to the methyltransferase superfamily. Type-7
CC       methyltransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB031280; BAB12278.1; -; mRNA.
DR   EMBL; EF526217; ABP98983.1; -; Genomic_DNA.
DR   EMBL; JX647690; AFV99128.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q9FZN8; -.
DR   SMR; Q9FZN8; -.
DR   KEGG; ag:BAB12278; -.
DR   BRENDA; 2.1.1.159; 1084.
DR   BRENDA; 2.1.1.160; 1084.
DR   SABIO-RK; Q9FZN8; -.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0102741; F:paraxanthine:S-adenosyl-L-methionine 3-N-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102740; F:theobromine:S-adenosyl-L-methionine 1-N-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009820; P:alkaloid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.1200.270; -; 1.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR005299; MeTrfase_7.
DR   InterPro; IPR042086; MeTrfase_capping.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR31009; PTHR31009; 1.
DR   Pfam; PF03492; Methyltransf_7; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
PE   1: Evidence at protein level;
KW   Alkaloid metabolism; Direct protein sequencing; Magnesium; Metal-binding;
KW   Methyltransferase; S-adenosyl-L-methionine; Transferase.
FT   CHAIN           1..369
FT                   /note="3,7-dimethylxanthine N-methyltransferase TCS1"
FT                   /id="PRO_0000408310"
FT   BINDING         24
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A0A6C0WW36"
FT   BINDING         24
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A4GE70"
FT   BINDING         24
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:A4GE70"
FT   BINDING         27..31
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:A4GE69"
FT   BINDING         65..66
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:Q9FLN8"
FT   BINDING         65
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A4GE69"
FT   BINDING         65
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A4GE70"
FT   BINDING         66
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A0A6C0WW36"
FT   BINDING         71
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A0A6C0WW36"
FT   BINDING         101..104
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A0A6C0WW36"
FT   BINDING         138..140
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A0A6C0WW36"
FT   BINDING         155..157
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A4GE69"
FT   BINDING         156..160
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A0A6C0WW36"
FT   BINDING         156..160
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:A4GE69"
FT   BINDING         177
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q9FLN8"
FT   BINDING         263
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q9FLN8"
FT   BINDING         265
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q9FLN8"
FT   BINDING         266
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q9FLN8"
FT   SITE            153
FT                   /note="Involved in substrate discrimination"
FT                   /evidence="ECO:0000269|PubMed:27116373"
FT   SITE            225
FT                   /note="Involved in substrate discrimination"
FT                   /evidence="ECO:0000269|PubMed:25133732"
FT   SITE            269
FT                   /note="Involved in substrate discrimination"
FT                   /evidence="ECO:0000269|PubMed:26773541"
FT   SITE            317
FT                   /note="Involved in substrate discrimination"
FT                   /evidence="ECO:0000269|PubMed:25133732"
FT   SITE            332
FT                   /note="Involved in substrate discrimination"
FT                   /evidence="ECO:0000269|PubMed:27116373"
FT   MUTAGEN         153
FT                   /note="H->Y: Increased theobromine synthase and caffeine
FT                   synthase activities."
FT                   /evidence="ECO:0000269|PubMed:27116373"
FT   MUTAGEN         225
FT                   /note="R->H: Reduced theobromine accumulation."
FT                   /evidence="ECO:0000269|PubMed:25133732"
FT   MUTAGEN         269
FT                   /note="S->C: Increased caffeine synthase activity, but
FT                   reduced theobromine synthase activity."
FT                   /evidence="ECO:0000269|PubMed:26773541"
FT   MUTAGEN         271
FT                   /note="F->W: Enhanced theobromine synthase and caffeine
FT                   synthase activities."
FT                   /evidence="ECO:0000269|PubMed:25133732"
FT   MUTAGEN         272
FT                   /note="A->P: Reduced theobromine accumulation."
FT                   /evidence="ECO:0000269|PubMed:25133732"
FT   MUTAGEN         317
FT                   /note="V->M: Enhanced theobromine synthase and caffeine
FT                   synthase activities."
FT                   /evidence="ECO:0000269|PubMed:25133732"
FT   MUTAGEN         332
FT                   /note="P->H: Reduced theobromine synthase activity, but
FT                   normal caffeine synthase activity."
FT                   /evidence="ECO:0000269|PubMed:27116373"
FT   CONFLICT        20
FT                   /note="G -> E (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        29
FT                   /note="S -> Q (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33
FT                   /note="Q -> V (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129
FT                   /note="P -> S (in Ref. 2; ABP98983 and 3; AFV99128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        300
FT                   /note="V -> L (in Ref. 2; ABP98983 and 3; AFV99128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        332
FT                   /note="P -> H (in Ref. 2; ABP98983 and 3; AFV99128)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   369 AA;  41272 MW;  E6D262087E475576 CRC64;
     MELATAGKVN EVLFMNRGEG ESSYAQNSSF TQQVASMAQP ALENAVETLF SRDFHLQALN
     AADLGCAAGP NTFAVISTIK RMMEKKCREL NCQTLELQVY LNDLFGNDFN TLFKGLSSEV
     IGNKCEEVPC YVMGVPGSFH GRLFPRNSLH LVHSSYSVHW LTQAPKGLTS REGLALNKGK
     IYISKTSPPV VREAYLSQFH EDFTMFLNAR SQEVVPNGCM VLILRGRQCS DPSDMQSCFT
     WELLAMAIAE LVSQGLIDED KLDTFNIPSY FASLEEVKDI VERDGSFTID HIEGFDLDSV
     EMQENDKWVR GEKFTKVVRA FTEPIISNQF GPEIMDKLYD KFTHIVVSDL EAKLPKTTSI
     ILVLSKIDG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024